Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Addus HomeCare
ADUS
$2.17B
| $10.2M | ﹤0.01% |
107,408
+8,215
| +8% | +$755K |
|
|
JRO
2952
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $10.2M | ﹤0.01% |
1,268,871
-122,732
| -9% | -$1.04M |
|
2953
Talos Energy
TALO
$2.63B
| $10.2M | ﹤0.01% |
614,146
-131,020
| -18% | -$2.35M |
|
2954
StepStone Group
STEP
$4.15B
| $10.2M | ﹤0.01% |
416,819
-1,799
| -0.4% | -$49K |
|
2955
FLEX LNG
FLNG
$1.67B
| $10.2M | ﹤0.01% |
321,500
+143,530
| +81% | +$4.55M |
|
2956
BridgeBio Pharma
BBIO
$15.6B
| $10.2M | ﹤0.01% |
1,023,814
-310,646
| -23% | -$3.23M |
|
2957
Invesco Quality Municipal Securities
IQI
$543M
| $10.2M | ﹤0.01% |
1,114,288
+135,433
| +14% | +$1.38M |
|
2958
Invesco Bloomberg Pricing Power ETF
POWA
$183M
| $10.2M | ﹤0.01% |
168,857
+102,223
| +153% | +$6.73M |
|
|
ETJ
2959
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$569M
| $10.1M | ﹤0.01% |
1,224,122
+290,603
| +31% | +$2.67M |
|
2960
Driven Brands
DRVN
$2.13B
| $10.1M | ﹤0.01% |
361,278
+83,655
| +30% | +$2.58M |
|
2961
Huron Consulting
HURN
$2.42B
| $10.1M | ﹤0.01% |
152,403
+10,350
| +7% | +$687K |
|
2962
Prothena Corp
PRTA
$455M
| $10.1M | ﹤0.01% |
166,499
-186,083
| -53% | -$5.88M |
|
|
AIMC
2963
DELISTED
Altra Industrial Motion Corp
AIMC
| $10.1M | ﹤0.01% |
300,176
-35,126
| -10% | -$1.34M |
|
2964
Nuveen Preferred & Income Opportunities Fund
JPC
$2.88B
| $10.1M | ﹤0.01% |
1,448,675
-677,154
| -32% | -$5.29M |
|
|
ERF
2965
DELISTED
Enerplus Corporation
ERF
| $10.1M | ﹤0.01% |
709,849
-95,135
| -12% | -$1.33M |
|
|
UCTT
2966
Ultra Clean Holdings
UCTT
$3.85B
| $10M | ﹤0.01% |
390,050
-47,109
| -11% | -$1.44M |
|
|
ALEX
2967
DELISTED
Alexander & Baldwin
ALEX
| $10M | ﹤0.01% |
605,574
-214,144
| -26% | -$3.94M |
|
2968
Iovance Biotherapeutics
IOVA
$3.16B
| $10M | ﹤0.01% |
1,048,000
-402,057
| -28% | -$4.64M |
|
2969
Ardagh Metal Packaging
AMBP
$3.13B
| $10M | ﹤0.01% |
2,072,800
+90,880
| +5% | +$554K |
|
2970
Invesco Pharmaceuticals ETF
PJP
$500M
| $10M | ﹤0.01% |
140,658
+11,173
| +9% | +$833K |
|
|
RXDX
2971
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $10M | ﹤0.01% |
169,854
+38,662
| +29% | +$1.77M |
|
2972
iShares MSCI Singapore ETF
EWS
$1.17B
| $10M | ﹤0.01% |
585,690
+18,316
| +3% | +$336K |
|
|
GRVY
2973
GRAVITY
GRVY
$489M
| $10M | ﹤0.01% |
213,855
-18,872
| -8% | -$934K |
|
2974
Pricesmart
PSMT
$5.56B
| $10M | ﹤0.01% |
173,764
-6,551
| -4% | -$424K |
|
|
HIE
2975
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $9.97M | ﹤0.01% |
1,099,554
+3,513
| +0.3% | +$34.9K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.